Scientists have known for a while that breast cancer is really four different diseases, with subtypes among them, an insight that has helped improve treatment for some women. But experts haven’t understood much about how these four types differ. A new report provides a big leap in that understanding. Matthew Meyerson, HMS professor of pathology at Dana-Farber Cancer Institute, is one of the study’s authors.
